Eterna Therapeutics Correlations

ERNA Stock

USD 0.19 0.01 5.56%

The current 90-days correlation between Eterna Therapeutics and Phio Pharmaceuticals Corp is -0.15 (i.e., Good diversification). The correlation of Eterna Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Eterna Therapeutics Correlation With Market

Good diversification

The correlation between Eterna Therapeutics and DJI is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Eterna Stock

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eterna Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Eterna Stock refer to our How to Trade Eterna Stock guide.

Moving together with Eterna Stock

0.84	VKTX	Viking Therapeutics Sell-off Trend	Pair Corr
0.76	ELEV	Elevation Oncology	Pair Corr
0.85	ENVB	Enveric Biosciences	Pair Corr
0.76	XFOR	X4 Pharmaceuticals	Pair Corr
0.66	PTN	Palatin Technologies	Pair Corr
0.81	GERN	Geron Earnings Call This Week	Pair Corr
0.72	HEPA	Hepion Pharmaceuticals	Pair Corr
0.76	ZURA	Zura Bio Limited	Pair Corr
0.69	IMMX	Immix Biopharma	Pair Corr
0.89	OCEA	Ocean Biomedical	Pair Corr
0.78	PDSB	PDS Biotechnology Corp	Pair Corr
0.61	REGN	Regeneron Pharmaceuticals Earnings Call This Week	Pair Corr
0.9	ABOS	Acumen Pharmaceuticals	Pair Corr
0.79	ALVO	Alvotech	Pair Corr
0.9	ANRO	Alto Neuroscience,	Pair Corr
0.66	APLM	Apollomics Class A	Pair Corr
0.78	SRPT	Sarepta Therapeutics Earnings Call This Week	Pair Corr
0.72	SYRE	Spyre Therapeutics	Pair Corr
0.86	TCRX	Tscan Therapeutics	Pair Corr
0.73	TELO	Telomir Pharmaceuticals,	Pair Corr
0.66	DH	Definitive Healthcare	Pair Corr

Moving against Eterna Stock

0.6	VALN	Valneva SE ADR	Pair Corr
0.44	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.8	CVS	CVS Health Corp Earnings Call This Week	Pair Corr
0.79	FNA	Paragon 28	Pair Corr
0.73	CI	Cigna Corp Earnings Call This Week	Pair Corr
0.61	ELV	Elevance Health	Pair Corr
0.59	TGTX	TG Therapeutics Earnings Call This Week	Pair Corr
0.45	MOH	Molina Healthcare Downward Rally	Pair Corr

Related Correlations Analysis

	RCUS	CGEM	ANNX	GPCR	RLAY	REVB	ZURA	PHIO	ZVSA	RNAZ
RCUS		0.94	0.94	0.9	0.95	0.81	0.84	0.41	0.91	0.82	RCUS
CGEM	0.94		0.94	0.9	0.94	0.7	0.9	0.41	0.82	0.8	CGEM
ANNX	0.94	0.94		0.88	0.95	0.73	0.84	0.3	0.82	0.7	ANNX
GPCR	0.9	0.9	0.88		0.92	0.66	0.85	0.57	0.76	0.68	GPCR
RLAY	0.95	0.94	0.95	0.92		0.78	0.84	0.43	0.85	0.75	RLAY
REVB	0.81	0.7	0.73	0.66	0.78		0.66	0.44	0.8	0.66	REVB
ZURA	0.84	0.9	0.84	0.85	0.84	0.66		0.47	0.72	0.7	ZURA
PHIO	0.41	0.41	0.3	0.57	0.43	0.44	0.47		0.41	0.33	PHIO
ZVSA	0.91	0.82	0.82	0.76	0.85	0.8	0.72	0.41		0.78	ZVSA
RNAZ	0.82	0.8	0.7	0.68	0.75	0.66	0.7	0.33	0.78		RNAZ
	RCUS	CGEM	ANNX	GPCR	RLAY	REVB	ZURA	PHIO	ZVSA	RNAZ

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Risk-Adjusted Indicators

There is a big difference between Eterna Stock performing well and Eterna Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eterna Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RCUS	3.41	(0.50)	0.00	(0.50)	0.00	0.00	5.83	(7.89)	22.17
CGEM	2.37	(0.27)	0.00	228.09	0.00	0.00	4.73	(4.73)	14.08
ANNX	4.59	(0.93)	0.00	(1.63)	0.00	0.00	8.29	(9.09)	26.72
GPCR	4.27	0.02	0.00	(0.11)	0.00	0.00	7.92	(10.88)	27.23
RLAY	4.36	(0.16)	0.00	(0.22)	0.00	0.00	7.33	(8.03)	20.43
REVB	5.03	(1.00)	0.00	2.28	0.00	0.00	9.82	(12.36)	49.44
ZURA	5.01	(0.13)	0.00	1.65	0.00	0.00	11.38	(9.04)	28.59
PHIO	5.46	0.57	0.06	0.08	5.65	(7.44)	11.11	(8.60)	71.20
ZVSA	6.33	0.54	0.00	(0.04)	0.00	0.00	7.86	(12.96)	144.21
RNAZ	11.80	(1.55)	0.00	(1.20)	0.00	0.00	45.13	(25.00)	95.99

Eterna Therapeutics Corporate Management

Andrew Jackson	Chief Officer	Profile
Robert MD	Chief Officer	Profile
Susan McClatchey	VP Quality	Profile
Sandra Gurrola	Principal Finance	Profile
Megan Yung	Chief Officer	Profile
Roger MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC